The prevalence of mitochondrial mutations associated with aminoglycoside-induced deafness in ethnic Latvian population: the appraisal of the evidence
暂无分享,去创建一个
[1] C. Lanvers-Kaminsky,et al. Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin. , 2017, Pharmacogenomics.
[2] Chunlei Liu,et al. ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..
[3] P. Steyger,et al. Aminoglycoside-Induced Cochleotoxicity: A Review , 2017, Front. Cell. Neurosci..
[4] M. Hallman,et al. Mitochondrial hearing loss mutations among Finnish preterm and term-born infants , 2017, Audiology research.
[5] Julia M. Barbarino,et al. PharmGKB summary: very important pharmacogene information for MT-RNR1 , 2016, Pharmacogenetics and genomics.
[6] A. Castilho,et al. Analysis of mitochondrial alterations in Brazilian patients with sensorineural hearing loss using MALDI-TOF mass spectrometry , 2016, BMC Medical Genetics.
[7] Yongli Guo,et al. Deafness gene mutations in newborns in Beijing , 2016, Acta oto-laryngologica.
[8] M. Guan,et al. Mitochondrial haplogroup B increases the risk for hearing loss among the Eastern Asian pedigrees carrying 12S rRNA 1555A>G mutation , 2015, Protein & Cell.
[9] B. Westerberg,et al. A meta-analysis and systematic review of the prevalence of mitochondrially encoded 12S RNA in the general population: Is there a role for screening neonates requiring aminoglycosides? , 2015, African journal of paediatric surgery : AJPS.
[10] V. Baumanis,et al. Genotypic and phenotypic characteristics of aminoglycoside-resistant Mycobacterium tuberculosis isolates in Latvia. , 2015, Diagnostic microbiology and infectious disease.
[11] S. Nishio,et al. Frequency of mitochondrial mutations in non-syndromic hearing loss as well as possibly responsible variants found by whole mitochondrial genome screening , 2014, Journal of Human Genetics.
[12] S. Volinia,et al. Association between idiopathic hearing loss and mitochondrial DNA mutations: A study on 169 hearing-impaired subjects , 2013, International journal of molecular medicine.
[13] D. Messineo,et al. Audiological and radiological characteristics of a family with T961G mitochondrial mutation , 2012, International journal of audiology.
[14] D. Strachan,et al. Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study , 2012, BMJ Open.
[15] K. Lynch,et al. The prevalence of mitochondrial mutations associated with aminoglycoside‐induced sensorineural hearing loss in an NICU population , 2011, The Laryngoscope.
[16] Ronghua Li,et al. Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss. , 2010, Mitochondrion.
[17] R. Płoski,et al. Mutation analysis of mitochondrial 12S rRNA gene in Polish patients with non-syndromic and aminoglycoside-induced hearing loss. , 2010, Biochemical and biophysical research communications.
[18] Mariana Postal,et al. Mutação mitocondrial C1494T, deficiência auditiva e uso de antibióticos aminoglicosídeos , 2009 .
[19] E. Sartorato,et al. C1494T mitochondrial dna mutation, hearing loss, and aminoglycosides antibiotics , 2009, Brazilian journal of otorhinolaryngology.
[20] O. Posukh,et al. Analysis of mitochondrial 12S rRNA and tRNASer(UCN) genes in patients with nonsyndromic sensorineural hearing loss from various regions of Russia , 2009, Russian Journal of Genetics.
[21] M. Rydzanicz,et al. Screening of the general Polish population for deafness-associated mutations in mitochondrial 12S rRNA and tRNA Ser(UCN) genes. , 2009, Genetic testing and molecular biomarkers.
[22] Manfred Kayser,et al. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation , 2009, Human mutation.
[23] M. Sarkar,et al. Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up , 2007, BMC ear, nose, and throat disorders.
[24] L. Gravina,et al. Carrier frequency of the 35delG and A1555G deafness mutations in the Argentinean population. Impact on the newborn hearing screening. , 2007, International journal of pediatric otorhinolaryngology.
[25] X. Bu,et al. Maternally inherited non-syndromic hearing loss associated with mitochondrial 12S rRNA A827G mutation in a Chinese family. , 2006, Biochemical and biophysical research communications.
[26] X. Estivill,et al. Cochlear alterations in deaf and unaffected subjects carrying the deafness-associated A1555G mutation in the mitochondrial 12S rRNA gene. , 2006, Biochemical and biophysical research communications.
[27] M. Guan. Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. , 2005, Mitochondrion.
[28] R. Villems,et al. Mitochondrial DNA Portrait of Latvians: Towards the Understanding of the Genetic Structure of Baltic‐Speaking Populations , 2005, Annals of human genetics.
[29] Selena E. Heman-Ackah,et al. Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss , 2005, Human Genetics.
[30] D. Choo,et al. Molecular analysis of the mitochondrial 12S rRNA and tRNASer(UCN) genes in paediatric subjects with non-syndromic hearing loss , 2004, Journal of Medical Genetics.
[31] J. Finsterer. Mitochondriopathies , 2004, European journal of neurology.
[32] Hui Zhao,et al. Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. , 2004, American journal of human genetics.
[33] M. Speer,et al. Genetic susceptibility to aminoglycoside ototoxicity: How many are at risk? , 2002, Genetics in Medicine.
[34] S. Dimauro,et al. A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy , 2000, Annals of neurology.
[35] S. Komune,et al. Prevalence of mitochondrial gene mutations among hearing impaired patients , 2000, Journal of medical genetics.
[36] X. Estivill,et al. The A1555G mutation in the 12S rRNA gene of human mtDNA: recurrent origins and founder events in families affected by sensorineural deafness. , 1999, American journal of human genetics.
[37] W. Tate,et al. The frequency in New Zealand of a mitochondrial DNA mutation (1555 A to G) associated with aminoglycoside-induced hearing loss. , 1999, The New Zealand medical journal.
[38] W. Kimberling,et al. Genetic and Clinical Features of Sensorineural Hearing Loss Associated With the 1555 Mitochondrial Mutation , 1997, The Laryngoscope.
[39] A. Torroni,et al. Classification of European mtDNAs from an analysis of three European populations. , 1996, Genetics.
[40] Mordechai Shohat,et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness , 1993, Nature Genetics.
[41] K. Higashi. Unique inheritance of streptomycininduced deafness , 1989 .
[42] Hinshaw Hc,et al. Auditory Ototoxicity in Tuberculosis Patients Treated with Dihydrostreptomycin: A Report of the Incidence of Hearing Loss in a Series of 1,150 Cases , 1963 .
[43] E. Zimmerman,et al. Ototoxicity in preterm infants: effects of genetics, aminoglycosides, and loud environmental noise , 2013, Journal of Perinatology.
[44] M. Kester. 4 – Treatment of Infectious Diseases , 2012 .
[45] Ronghua Li,et al. Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation. , 2010, Mitochondrion.
[46] E. Selimoğlu,et al. Aminoglycoside-induced ototoxicity. , 2007, Current pharmaceutical design.
[47] K. Vrana,et al. Treatment of Infectious Diseases , 2007 .
[48] S. Claes,et al. Non-Syndromic Deafness Associated with a Mutation and a Polymorphism in the Mitochondrial 12S Ribosomal RNA Gene in a Large Zairean Pedigree , 1996, European journal of human genetics : EJHG.
[49] K. Higashi. Unique inheritance of streptomycin-induced deafness. , 1989, Clinical genetics.
[50] H. Hinshaw,et al. AUDITORY OTOTOXICITY IN TUBERCULOSIS PATIENTS TREATEDWITH A REPORT OF THE INCIDENCE OF HEARING LOSS IN A SERIES OF 1,150 CASES. , 1963, Journal of the American Medical Association (JAMA).